KJ-TFC-004 Drug-drug Interaction Study

• Status: Completed
• Trial end date: 2018-04-01
• Target enrollment: 0
• Participant gender: Male

Summary

To assess the pharmacokinetic Interaction between Dorzolamide and Brimonidine in healthy male subjects.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Kukje Pharma
• Treatments: Brimonidine Tartrate; Dorzolamide; Ophthalmic Solutions; Tetrahydrozoline; Timolol

Criteria

Inclusion Criteria:

• Healthy male adults aged between 19 and 50 during screening period

• BMI more than 18kg / m2 and less than 30kg / m2 and weight more than 55kg

• Signed the informed consent form prior to study participation.

Exclusion Criteria:

• Presence of medical history or a concurrent disease that may interfere with treatment and safety assessment or completion of this clinical study, including clinically significant disorders in kidney, liver, cardiovascular system, respiratory system, endocrine system, or neuropsychiatric system.